Mr. Dollens served as President and CEO of Guidant, a $3.7 billion company, since its initial public offering in 1994 and oversaw its split-off from parent Eli Lilly and Company in 1995. Prior to forming Guidant, Mr. Dollens was President of Eli Lilly’s Medical Devices and Diagnostics Division (MDD).

 Mr. Dollens’ industry leadership includes the position as past director and chairman of the Board of the Advanced Medical Technology Association (AdvaMed), the world’s largest medical technology association; as well as past Chairman of the Healthcare Leadership Counsel. He has served on the Advisory Committee on Regulatory Reform, a group appointed by former U.S. Health and Human Services Secretary Tommy G. Thompson. Mr Dollens’ community involvement includes past chairman of the United Way of Central Indiana, director positions for the Eiteljorg Museum, the Regenstrief Institute Foundation, the Alliance for Aging Research, and Butler University. He offers an advisory role for Purdue University, Rose Hulman Institute of Technology, Duke University’s Pratt School of Engineering and holds the Harold A. "Red" Poling Chair for Business and Government at Indiana University. Mr. Dollens was a founding board member of Guidant Corporation and is currently the non executive Chairman of the Board of Kenetic Concepts, Inc.